Epstein File EFTA01092057: Solicitation, Classified and Treat (DS9)

Epstein Index›Documents›EFTA01092057

💨IMPACT LEVEL 1 — MEH

Epstein File EFTA01092057: Solicitation, Classified and Treat (DS9)

Financial RecordDate unavailableEFTA010920571 keyword hits

0

views

0

shares

0

reactions

0

persons

4

keywords

5

excerpts

This document is a Maxim Equity Research report analyzing cell therapy treatments for chronic wounds under FDA regulatory pathway 21 C.F.R. Part 1271. It discusses IntelliCell Biosciences and Cytori cell products, including requirements for minimal manipulation and homologous use. The document includes standard securities disclaimers stating it is not a solicitation to buy or sell securities.

👤 Named in This Document

No named persons linked yet

🔑 Evidence Keywords

solicitation classified treat manipulated

📋 Key Excerpts5

PersonKeyword

Excerpt 1

This communication is neither an offer to sell nor a **solicitation** of an offer to buy any securities mentioned herein.

Excerpt 2

As we understand actions generally **classified** as chemical or biological in nature have a greater likelihood of altering characteristics of the cells.

Excerpt 3

It has been sold in the U.S. to *Closing prices (8/15/2013) **treat** chronic wounds, under FDA regulatory pathway 21 C.F.R. Part 1271.